Cocrystal Pharma Inc (COCP)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current COCP market cap is 18.31M. The company's latest EPS is USD -1.7205 and P/E is -1.05.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.16M | -5.45M | -5.04M | -3.23M | -2.34M |
| Net Income | -3.96M | -5.34M | -4.94M | -3.27M | -2.3M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.01M | 0 | 0 | 2.6M | 0 |
| Operating Income | -9.59M | -14.22M | -19.74M | -18.56M | -17.88M |
| Net Income | -9.65M | -14.19M | -38.84M | -17.98M | -17.5M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 26.55M | 21.57M | 16.23M | 13.46M | 10.66M |
| Total Liabilities | 3.96M | 4.18M | 3.53M | 3.93M | 3.36M |
| Total Equity | 22.59M | 17.39M | 12.7M | 9.52M | 7.3M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 54.24M | 79.39M | 40.84M | 31.26M | 13.46M |
| Total Liabilities | 1.74M | 1.84M | 1.27M | 4.88M | 3.93M |
| Total Equity | 52.51M | 77.55M | 39.57M | 26.38M | 9.52M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.5M | -8.2M | -13.33M | -16.49M | -2.94M |
| Investing | -8k | -8k | -8k | -8k | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.83M | -12.72M | -21.44M | -14.67M | -16.49M |
| Investing | -240k | -52k | -74k | -118k | -8k |
| Financing | 35.66M | 38.47M | -27k | 3.99M | N/A |
| Market Cap | 18.31M |
| Price to Earnings Ratio | -1.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.86 |
| Price to Book Ratio | 1.92 |
| Dividend Yield | - |
| Shares Outstanding | 10.17M |
| Average Volume (1 week) | 13.86k |
| Average Volume (1 Month) | 17.05k |
| 52 Week Change | -20.00% |
| 52 Week High | 3.26 |
| 52 Week Low | 1.10 |
| Spread (Intraday) | 0.15 (8.33%) |
| Company Name | Cocrystal Pharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.cocrystalpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
